After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...